Lyle Arnold, Michael Dunn, Gilbert Omenn, Matthew Potter, David Bartel, Arthur Beaudet, George Church
Lyle Arnold, Michael Dunn join Biocept management team; HTG appoints John Lubniewski as chief business officer; Ora Hirsch Pescovitz joins Life Tech's board
The company's first test, a FISH-based assay targeting breast cancer, is planned for October and would represent its first product introduction in its 13-year history.
Rosetta Genomics, Hitachi, Biocept, Brigham and Women's Hospital, Tufts University
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.